Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |